Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Synaptogenix (SNPX.US)$ Reuters· just
Synaptogenix Announces FDA Authorization of Ind Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
Translate
Report
2413 Views
Comment
Sign in to post a comment